EUVIMEDEUVIMED entdecken
Open Access

Impact of Statin Nonacceptance on Cardiovascular Outcomes in Patients With Diabetes

Nisarg Shah iD, Zhou Lan, C Justin Brown, Seth S Martin iD, Alexander Turchin iD

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.124.040464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Nisarg Shah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Yale School of Medicine New Haven CT USA. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Diabetes Mellitus, Myocardial Infarction, Cardiovascular Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Many patients with diabetes do not accept statin therapy despite being at increased risk for cardiovascular events compared with the general population. The effects of delaying statin therapy are not well‐understood.

Methods

This is a retrospective cohort study that followed adults with diabetes and no preexisting atherosclerotic cardiovascular disease at the Mass General Brigham integrated health system between 2000 and 2018. The exposure was immediate versus delayed statin acceptance by patients who were recommended statin therapy. The primary outcome was the composite incidence of myocardial infarction and ischemic stroke.

Results

Among the 7239 study patients, the median age was 55.0 years, and 52.0% were women. Within this cohort, 1280 (17.7%) delayed statin therapy by a mean±SD of 2.7±3.1 years. Patients who delayed statin therapy had higher mean low‐density lipoprotein cholesterol levels while they were not prescribed a statin (126.4 versus 99.2 mg/dL, P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsDiabetes MellitusMyocardial InfarctionCardiovascular DiseasesIschemic StrokeDyslipidemiasTime-to-TreatmentHumansFemaleMiddle AgedMaleRetrospective StudiesAgedIncidenceTime FactorsCholesterol, LDLRisk AssessmentRisk FactorsTreatment Outcome

Stichwörter der Autor:innen

cardiovascular outcomesdiabeteslow‐density lipoprotein cholesterolmedication nonacceptanceprimary preventionshared decision‐makingstatin

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsCholesterol, LDL

Autor:innen und Institutionen

  • Yale School of Medicine New Haven CT USA.
  • Brigham and Women's Hospital Boston MA USA.
  • Harvard Medical School Boston MA USA.
  • Tufts Medical Center Boston MA USA.
  • The Johns Hopkins Hospital Baltimore MD USA.

ORCID-Profile: Nisarg Shah, Seth S Martin, Alexander Turchin

Zitieren

APA

Shah, N., Lan, Z., Brown, C. J., Martin, S. S., & Turchin, A. (2025). Impact of Statin Nonacceptance on Cardiovascular Outcomes in Patients With Diabetes. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.040464

Vancouver

Shah N, Lan Z, Brown CJ, Martin SS, Turchin A. Impact of Statin Nonacceptance on Cardiovascular Outcomes in Patients With Diabetes. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.040464

BibTeX
@article{Shah2025,
  author = {Shah, Nisarg and Lan, Zhou and Brown, C Justin and Martin, Seth S and Turchin, Alexander},
  title = {Impact of Statin Nonacceptance on Cardiovascular Outcomes in Patients With Diabetes},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.124.040464}
}
Kostenlos starten →